Logo
Logo

About Dimethyl Fumarate API

Product
  • Therapeutic CategoryCentral Nervous System (CNS)

  • CAS Number

    624-49-7

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Capsules

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, EUDMF, Brazil DMF, China DMF

Mechanism of Action

The mechanism by which dimethyl fumarate (DMF) exerts its therapeutic effect in multiple sclerosis is unknown. DMF and the metabolite, monomethyl fumarate (MMF), have been shown to activate the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway in vitro and in vivo in animals and humans. The Nrf2 pathway is involved in the cellular response to oxidative stress. MMF has been identified as a nicotinic acid receptor agonist in vitro.

Indication

TECFIDERA is indicated for the treatment of patients with relapsing forms of multiple sclerosis

Related APIs

Atomoxetine Hydrochloride

Central Nervous System (CNS)

arrow

Benztropine Mesylate

Central Nervous System (CNS)

arrow

Dimethyl Fumarate

Central Nervous System (CNS)

arrow

Edaravone

Central Nervous System (CNS)

arrow

Eslicarbazepine Acetate

Central Nervous System (CNS)

arrow

Eszopiclone

Central Nervous System (CNS)

arrow

Levetiracetam

Central Nervous System (CNS)

arrow

Lumateperone Tosylate

Central Nervous System (CNS)

arrow

Lurasidone Hydrochloride

Central Nervous System (CNS)

arrow

Memantine Hydrochloride

Central Nervous System (CNS)

arrow

Pregabalin

Central Nervous System (CNS)

arrow

Rimegepant

Central Nervous System (CNS)

arrow

Risperidone

Central Nervous System (CNS)

arrow

Rivastigmine Hydrogen Tartrate

Central Nervous System (CNS)

arrow

Ropinirole Hydrochloride

Central Nervous System (CNS)

arrow

Sugammadex Sodium

Central Nervous System (CNS)

arrow

Tizanidine Hydrochloride

Central Nervous System (CNS)

arrow

Xanomeline

Central Nervous System (CNS)

arrow

Fluoxetine

Central Nervous System (CNS)

arrow

Quetiapine Fumarate

Central Nervous System (CNS)

arrow

Apremilast (form B)

Central Nervous System (CNS)

arrow

Donepezil Hydrochloride

Central Nervous System (CNS)

arrow

Siponimod Hemifumarate

Central Nervous System (CNS)

arrow

Ziprasidone Hydrochloride Anhydrous

Central Nervous System (CNS)

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone

FAQs

How do you store Dimethyl Fumarate API?
  • Store at temperature  2 – 8°C

What is the use of Dimethyl Fumarate?
  • Dimethyl fumarate is used to treat adults with relapsing forms of multiple sclerosis

What precautions need to be taken while having Dimethyl Fumarate?
  • Avoid being near people who are sick or have infections while you are using this medicine.

What is the dosage form available for Dimethyl Fumarate API ?
  • Dimethyl fumarate is available in capsule dosage form with 120 and 240 mg

What polymorph form is available for Dimethyl fumarate?
  • We offer Crystalline Form of Dimethyl Fumarate

What is the BCS classification for Dimethyl fumarate?

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.